Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Spain's Biomar Microbial Technologies has invested €2m in the expansion of its León factory to produce Active Pharmaceutical Ingredients (APIs) for the pharmacy, cosmetics, food, agriculture and energy sectors.
Subscribe to our email newsletter
The investment will expand the production of active raw materials to over 3,000ltrs.
The expanded facility is dedicated to the production of small molecules and proteins which require bacteria, fungi and yeast fermentation processes or the cultivation of mammalian cells for the completion of preclinical and clinical studies.
Biomar Microbial Technologies managing director Antonio Fernandez Medarde said they have met GMP quality standards applying to international external laboratories and the large-scale production of pharmaceuticals.
The firm will enable faster production with respect to price, quality and safety, preventing contamination.
The company executives said they currently offer the cost-effective conditions in each phase of the API R&D process, in the least amount of time, with the best safety guarantees.